<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583947</url>
  </required_header>
  <id_info>
    <org_study_id>091-029</org_study_id>
    <nct_id>NCT00583947</nct_id>
  </id_info>
  <brief_title>A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects</brief_title>
  <official_title>A Cumulative Dose Safety and Tolerability Crossover Study of Arformoterol Tartrate Inhalation Solution and Levalbuterol Hydrochloride Inhalation Solution in Pediatric Subjects (Aged 2 to 11 Years of Age) With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunovion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunovion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the safety and tolerability of Arformoterol Tartrate in children with asthma
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double-blind two-way crossover study of three cumulative doses of arformoterol
      (7.5 ug per nebulization) and levalbuterol (0.63 mg per nebulization) given over a one hour
      period, followed by a single open-label treatment day with three cumulative doses of
      arformoterol 15 ug in subjects 2-11 years of age with asthma. This study was previously
      posted by Sepracor Inc. In October 2009, Sepracor Inc. was acquired by Dainippon Sumitomo
      Pharma., and in October 2010, Sepracor Inc's name was changed to Sunovion Pharmaceuticals
      Inc.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Heart Rate</measure>
    <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
    <description>Heart rate measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Predose in Mean Heart Rate</measure>
    <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
    <description>Heart rate measured at various timepoints minus the heart rate at predose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Systolic Blood Pressure</measure>
    <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
    <description>Systolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Predose in Mean Systolic Blood Pressure</measure>
    <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
    <description>Mean systolic blood pressure measured at various timepoints minus the mean systolic blood pressure at predose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Diastolic Blood Pressure</measure>
    <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
    <description>Diastolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Predose in Mean Diastolic Blood Pressure</measure>
    <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
    <description>Mean diastolic blood pressure measured at various timepoints minus the predose diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Serum Potassium Levels</measure>
    <time_frame>Predose, 2 hours and 6 hours postdose 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Predose in Mean Serum Potassium</measure>
    <time_frame>predose, 2 and 6 hours post dose</time_frame>
    <description>Change in mean serum potassium at the specified timepoint minus the predose value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Serum Glucose Values</measure>
    <time_frame>Predose, 2 and 6 hours post dose 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Predose in Mean Serum Glucose</measure>
    <time_frame>predose, 2 and 6 hours post dose</time_frame>
    <description>Change in mean serum glucose at the specified timepoint minus the predose value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Forced Expiratory Volume in One Second(FEV1)</measure>
    <time_frame>predose, various postdose times</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Predose of Mean Forced Expiratory Volume in One Second (FEV1)</measure>
    <time_frame>predose, various postdose timepoints</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. Change in FEV1 was calculated as postdose value minus the predose value at each visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Peak Expiratory Flow Rate (PEFR)</measure>
    <time_frame>predose, various postdose times</time_frame>
    <description>PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Predose in Mean Peak Expiratory Flow Rate (PEFR)</measure>
    <time_frame>predose, various postdose times</time_frame>
    <description>PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters. Change in PEFR was calculated as postdose value minus the predose value at each visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma Concentration of (R,R) Formoterol</measure>
    <time_frame>predose, various postdose times</time_frame>
    <description>If the mean plasma concentration was 'below the limit of quantification' (BLQ) which was set as &lt;=0.5 picograms/milliliter, the value is displayed as a zero.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>ARF/LEV</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cross-over phase: one day active treatment with arformoterol 7.5 microgram per nebulization followed by a 7 day washout. Then a one day active treatment with levalbuterol 0.63 milligram per nebulization.
Open-label phase: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LEV/ARF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cross-over phase: one day active treatment with levalbuterol 0.63 milligram per nebulization followed by a 7 day washout. Then a one day active treatment with arformoterol 7.5 micrograms per nebulization.
Open-label phase: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>arformoterol</intervention_name>
    <description>Arformoterol is given at a 7.5 ug per dosing during the cross-over phase and 15 ug per dosing during the open-label phase. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
    <arm_group_label>ARF/LEV</arm_group_label>
    <arm_group_label>LEV/ARF</arm_group_label>
    <other_name>Brovana</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levalbuterol</intervention_name>
    <description>Levalbuterol is given at a 0.63 mg per dosing during the cross-over phase. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
    <arm_group_label>ARF/LEV</arm_group_label>
    <arm_group_label>LEV/ARF</arm_group_label>
    <other_name>Xopenex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Female

          -  Between Age 2 and 11, inclusive, at the time of consent

          -  Weight equal to or greater than 15 Kg

          -  History of physician-diagnosed asthma of at least 2 years duration for children age 6
             and older, and at least 1 year duration for children 5 and younger.

        Exclusion Criteria:

          -  Female subject who is pregnant or lactating.

          -  Subject who has a history of hospitalization for asthma within one year, or who is
             scheduled for in-patient hospitalization, including elective surgery during the course
             of the trial.

          -  Subject with any history of life-threatening asthma defined as a history of asthma
             episodes requiring intubation, associated with hypercapnia, respiratory arrest, or
             hypoxic seizures.

          -  Subject with a history of cancer.

          -  Subject with hyperthyroidism, diabetes, hypertension, cardiac diseases or seizure
             disorders.

          -  Subject with a history of cigarette smoking or use of any tobacco products.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pulmonary Medical Director</last_name>
    <role>Study Chair</role>
    <affiliation>Unicorn Pharma Consulting</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Upland</city>
        <state>Pennsylvania</state>
        <zip>19013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hinkle J, Hinson J, Kerwin E, Goodwin E, Sciarappa K, Curry L, Hanrahan JP. A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma. Pediatr Pulmonol. 2011 Aug;46(8):761-9. doi: 10.1002/ppul.21446. Epub 2011 May 16.</citation>
    <PMID>21584948</PMID>
  </results_reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2008</study_first_posted>
  <results_first_submitted>November 30, 2009</results_first_submitted>
  <results_first_submitted_qc>January 19, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 8, 2010</results_first_posted>
  <last_update_submitted>February 21, 2012</last_update_submitted>
  <last_update_submitted_qc>February 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
    <mesh_term>Formoterol Fumarate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>86 subjects were screened: 23 subjects aged 2-5 years and 63 subjects aged 6-11 years.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ARF/LEV</title>
          <description>Cross-over period: one day active treatment with arformoterol 7.5 microgram per nebulization followed by a 7 day washout. Then a one day active treatment with levalbuterol 0.63 milligram per nebulization.
Open-label period: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization.</description>
        </group>
        <group group_id="P2">
          <title>LEV/ARF</title>
          <description>Cross-over period: one day active treatment with levalbuterol 0.63 milligram per nebulization followed by a 7 day washout. Then a one day active treatment with arformoterol 7.5 micrograms per nebulization.
Open-label period: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Cross-over Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27">Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years</participants>
                <participants group_id="P2" count="26">Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not meet-no longer met entry criteri</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>not specified</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Washout</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Open Label Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22">3 subjects were dosed with arformoterol 7.5 microgram in error</participants>
                <participants group_id="P2" count="24">3 subjects were dosed with arformoterol 7.5 microgram in error</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ARF/LEV</title>
          <description>Cross-over: Participants treated with arformoterol 7.5 microgram per nebulization; 7 day washout; levalbuterol 0.63 milligram per nebulization.
Open label: 7 day washout; arformoterol 15 microgram per nebulization.</description>
        </group>
        <group group_id="B2">
          <title>LEV/ARF</title>
          <description>Cross-over: Participants treated with levalbuterol 0.63 milligram per nebulization; 7 day washout; arformoterol 7.5 microgram per nebulization.
Open label: 7 day washout; arformoterol 15 microgram per nebulization.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age 2-5 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.4" spread="0.79"/>
                    <measurement group_id="B2" value="4.4" spread="0.79"/>
                    <measurement group_id="B3" value="4.4" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age 6-11 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.0" spread="1.26"/>
                    <measurement group_id="B2" value="8.5" spread="1.43"/>
                    <measurement group_id="B3" value="8.8" spread="1.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White/Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black/African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="131.62" spread="15.244"/>
                    <measurement group_id="B2" value="130.42" spread="15.377"/>
                    <measurement group_id="B3" value="131.03" spread="15.174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.57" spread="12.106"/>
                    <measurement group_id="B2" value="32.68" spread="12.802"/>
                    <measurement group_id="B3" value="32.12" spread="12.345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Heart Rate</title>
        <description>Heart rate measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
        <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Heart Rate</title>
          <description>Heart rate measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
          <population>Intent to treat population</population>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Predose (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.6" spread="12.56"/>
                    <measurement group_id="O2" value="84.7" spread="14.11"/>
                    <measurement group_id="O3" value="87.0" spread="17.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.3" spread="15.57"/>
                    <measurement group_id="O2" value="85.2" spread="15.19"/>
                    <measurement group_id="O3" value="89.4" spread="16.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" spread="14.47"/>
                    <measurement group_id="O2" value="86.6" spread="14.63"/>
                    <measurement group_id="O3" value="89.5" spread="15.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 1 (n=51,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.4" spread="12.33"/>
                    <measurement group_id="O2" value="89.0" spread="13.67"/>
                    <measurement group_id="O3" value="93.5" spread="16.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 2 (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.4" spread="12.94"/>
                    <measurement group_id="O2" value="87.5" spread="14.88"/>
                    <measurement group_id="O3" value="92.5" spread="18.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 2 (n=47,50,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.1" spread="13.28"/>
                    <measurement group_id="O2" value="88.9" spread="13.33"/>
                    <measurement group_id="O3" value="93.3" spread="16.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 2 (n=46,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.4" spread="16.60"/>
                    <measurement group_id="O2" value="89.3" spread="13.97"/>
                    <measurement group_id="O3" value="96.1" spread="12.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.2" spread="17.38"/>
                    <measurement group_id="O2" value="90.3" spread="14.24"/>
                    <measurement group_id="O3" value="96.1" spread="13.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.0" spread="16.45"/>
                    <measurement group_id="O2" value="93.3" spread="13.06"/>
                    <measurement group_id="O3" value="97.1" spread="14.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours post last dose (n=48,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.2" spread="17.29"/>
                    <measurement group_id="O2" value="91.8" spread="11.75"/>
                    <measurement group_id="O3" value="95.3" spread="16.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.0" spread="16.23"/>
                    <measurement group_id="O2" value="91.2" spread="11.77"/>
                    <measurement group_id="O3" value="95.9" spread="14.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.5 hours post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.1" spread="16.22"/>
                    <measurement group_id="O2" value="90.2" spread="14.61"/>
                    <measurement group_id="O3" value="94.8" spread="15.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.1" spread="14.84"/>
                    <measurement group_id="O2" value="90.6" spread="13.57"/>
                    <measurement group_id="O3" value="93.4" spread="16.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.3" spread="14.65"/>
                    <measurement group_id="O2" value="89.8" spread="13.20"/>
                    <measurement group_id="O3" value="95.0" spread="15.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.0" spread="12.68"/>
                    <measurement group_id="O2" value="89.3" spread="11.76"/>
                    <measurement group_id="O3" value="94.5" spread="14.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.3" spread="13.71"/>
                    <measurement group_id="O2" value="89.6" spread="12.50"/>
                    <measurement group_id="O3" value="93.9" spread="16.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours post last dose (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.4" spread="15.36"/>
                    <measurement group_id="O2" value="89.8" spread="14.16"/>
                    <measurement group_id="O3" value="92.9" spread="14.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Forced Expiratory Volume in One Second(FEV1)</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer.</description>
        <time_frame>predose, various postdose times</time_frame>
        <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Forced Expiratory Volume in One Second(FEV1)</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer.</description>
          <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>predose (n=37,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.554" spread="0.374"/>
                    <measurement group_id="O2" value="1.552" spread="0.377"/>
                    <measurement group_id="O3" value="1.486" spread="0.294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 1 (n=37,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.714" spread="0.411"/>
                    <measurement group_id="O2" value="1.668" spread="0.403"/>
                    <measurement group_id="O3" value="1.620" spread="0.315"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 1 (n=37,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.712" spread="0.425"/>
                    <measurement group_id="O2" value="1.695" spread="0.409"/>
                    <measurement group_id="O3" value="1.644" spread="0.334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.741" spread="0.430"/>
                    <measurement group_id="O2" value="1.721" spread="0.420"/>
                    <measurement group_id="O3" value="1.661" spread="0.332"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.735" spread="0.438"/>
                    <measurement group_id="O2" value="1.714" spread="0.423"/>
                    <measurement group_id="O3" value="1.669" spread="0.331"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 3 (n=34,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.775" spread="0.402"/>
                    <measurement group_id="O2" value="1.731" spread="0.419"/>
                    <measurement group_id="O3" value="1.689" spread="0.340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 3 (n=35,38,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.782" spread="0.415"/>
                    <measurement group_id="O2" value="1.740" spread="0.419"/>
                    <measurement group_id="O3" value="1.700" spread="0.345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=36,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.784" spread="0.397"/>
                    <measurement group_id="O2" value="1.754" spread="0.408"/>
                    <measurement group_id="O3" value="1.704" spread="0.337"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.732" spread="0.401"/>
                    <measurement group_id="O2" value="1.722" spread="0.423"/>
                    <measurement group_id="O3" value="1.684" spread="0.344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.667" spread="0.400"/>
                    <measurement group_id="O2" value="1.725" spread="0.426"/>
                    <measurement group_id="O3" value="1.660" spread="0.356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Predose in Mean Heart Rate</title>
        <description>Heart rate measured at various timepoints minus the heart rate at predose.</description>
        <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose in Mean Heart Rate</title>
          <description>Heart rate measured at various timepoints minus the heart rate at predose.</description>
          <population>Intent to treat population</population>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="10.27"/>
                    <measurement group_id="O2" value="0.5" spread="9.40"/>
                    <measurement group_id="O3" value="2.3" spread="10.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="11.91"/>
                    <measurement group_id="O2" value="2.0" spread="11.06"/>
                    <measurement group_id="O3" value="2.5" spread="11.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 1 (n=51,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="10.70"/>
                    <measurement group_id="O2" value="4.4" spread="11.85"/>
                    <measurement group_id="O3" value="6.5" spread="12.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 2 (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8" spread="10.72"/>
                    <measurement group_id="O2" value="2.8" spread="11.48"/>
                    <measurement group_id="O3" value="5.5" spread="12.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 2 (n=47,50,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" spread="10.67"/>
                    <measurement group_id="O2" value="4.5" spread="10.46"/>
                    <measurement group_id="O3" value="6.3" spread="12.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 2 (n=46,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.2" spread="13.81"/>
                    <measurement group_id="O2" value="4.7" spread="10.50"/>
                    <measurement group_id="O3" value="9.5" spread="12.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" spread="14.11"/>
                    <measurement group_id="O2" value="5.6" spread="11.44"/>
                    <measurement group_id="O3" value="9.0" spread="13.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="13.97"/>
                    <measurement group_id="O2" value="8.6" spread="14.06"/>
                    <measurement group_id="O3" value="10.0" spread="14.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours post last dose (n=48,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.9" spread="11.73"/>
                    <measurement group_id="O2" value="7.1" spread="12.65"/>
                    <measurement group_id="O3" value="8.3" spread="15.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="12.13"/>
                    <measurement group_id="O2" value="6.6" spread="10.77"/>
                    <measurement group_id="O3" value="8.9" spread="12.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.5 hours post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="11.20"/>
                    <measurement group_id="O2" value="5.5" spread="14.33"/>
                    <measurement group_id="O3" value="7.8" spread="13.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="10.94"/>
                    <measurement group_id="O2" value="5.9" spread="12.74"/>
                    <measurement group_id="O3" value="6.4" spread="13.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="11.89"/>
                    <measurement group_id="O2" value="5.1" spread="11.63"/>
                    <measurement group_id="O3" value="7.9" spread="12.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="10.30"/>
                    <measurement group_id="O2" value="4.6" spread="13.51"/>
                    <measurement group_id="O3" value="7.4" spread="11.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="10.86"/>
                    <measurement group_id="O2" value="4.9" spread="12.00"/>
                    <measurement group_id="O3" value="6.9" spread="12.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours post last dose (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="12.03"/>
                    <measurement group_id="O2" value="5.3" spread="12.41"/>
                    <measurement group_id="O3" value="5.8" spread="12.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Systolic Blood Pressure</title>
        <description>Systolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
        <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Systolic Blood Pressure</title>
          <description>Systolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
          <population>Intent to treat population</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Predose (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.1" spread="10.80"/>
                    <measurement group_id="O2" value="101.5" spread="9.86"/>
                    <measurement group_id="O3" value="100.6" spread="10.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.9" spread="10.90"/>
                    <measurement group_id="O2" value="101.2" spread="11.07"/>
                    <measurement group_id="O3" value="102.6" spread="11.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.6" spread="12.08"/>
                    <measurement group_id="O2" value="102.5" spread="10.20"/>
                    <measurement group_id="O3" value="100.3" spread="9.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 1 (n=51,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.8" spread="9.31"/>
                    <measurement group_id="O2" value="102.7" spread="9.82"/>
                    <measurement group_id="O3" value="103.2" spread="10.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 2 (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.0" spread="11.20"/>
                    <measurement group_id="O2" value="101.7" spread="9.42"/>
                    <measurement group_id="O3" value="102.1" spread="12.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 2 (n=47,50,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.4" spread="10.32"/>
                    <measurement group_id="O2" value="102.8" spread="9.26"/>
                    <measurement group_id="O3" value="101.9" spread="9.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 2 (n=46,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.2" spread="12.05"/>
                    <measurement group_id="O2" value="101.9" spread="11.18"/>
                    <measurement group_id="O3" value="102.9" spread="9.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.0" spread="12.22"/>
                    <measurement group_id="O2" value="101.2" spread="11.72"/>
                    <measurement group_id="O3" value="101.6" spread="12.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.1" spread="10.32"/>
                    <measurement group_id="O2" value="103.0" spread="11.87"/>
                    <measurement group_id="O3" value="104.9" spread="11.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours post last dose (n=48,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.8" spread="11.43"/>
                    <measurement group_id="O2" value="101.9" spread="11.67"/>
                    <measurement group_id="O3" value="103.0" spread="10.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.6" spread="11.40"/>
                    <measurement group_id="O2" value="103.4" spread="10.81"/>
                    <measurement group_id="O3" value="101.8" spread="10.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.5 hours post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.0" spread="12.41"/>
                    <measurement group_id="O2" value="101.5" spread="10.58"/>
                    <measurement group_id="O3" value="101.3" spread="10.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.1" spread="12.28"/>
                    <measurement group_id="O2" value="102.1" spread="10.84"/>
                    <measurement group_id="O3" value="101.9" spread="11.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.4" spread="10.00"/>
                    <measurement group_id="O2" value="103.2" spread="11.38"/>
                    <measurement group_id="O3" value="101.4" spread="9.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.6" spread="11.26"/>
                    <measurement group_id="O2" value="102.1" spread="10.14"/>
                    <measurement group_id="O3" value="100.5" spread="10.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.5" spread="10.50"/>
                    <measurement group_id="O2" value="103.2" spread="10.96"/>
                    <measurement group_id="O3" value="101.5" spread="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.7" spread="9.94"/>
                    <measurement group_id="O2" value="104.1" spread="10.46"/>
                    <measurement group_id="O3" value="102.1" spread="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Predose in Mean Systolic Blood Pressure</title>
        <description>Mean systolic blood pressure measured at various timepoints minus the mean systolic blood pressure at predose</description>
        <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose in Mean Systolic Blood Pressure</title>
          <description>Mean systolic blood pressure measured at various timepoints minus the mean systolic blood pressure at predose</description>
          <population>Intent to treat population</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="10.58"/>
                    <measurement group_id="O2" value="-0.4" spread="9.57"/>
                    <measurement group_id="O3" value="2.0" spread="8.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="10.14"/>
                    <measurement group_id="O2" value="0.9" spread="6.97"/>
                    <measurement group_id="O3" value="-0.3" spread="7.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 1 (n=51,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="8.60"/>
                    <measurement group_id="O2" value="1.1" spread="9.54"/>
                    <measurement group_id="O3" value="2.6" spread="7.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 2 (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="8.94"/>
                    <measurement group_id="O2" value="-0.3" spread="9.28"/>
                    <measurement group_id="O3" value="1.6" spread="9.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 2 (n=47,50,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="8.59"/>
                    <measurement group_id="O2" value="0.8" spread="9.01"/>
                    <measurement group_id="O3" value="1.4" spread="7.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 2 (n=46,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="7.89"/>
                    <measurement group_id="O2" value="-0.3" spread="8.98"/>
                    <measurement group_id="O3" value="1.8" spread="8.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="10.72"/>
                    <measurement group_id="O2" value="-0.4" spread="9.37"/>
                    <measurement group_id="O3" value="1.1" spread="11.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="10.92"/>
                    <measurement group_id="O2" value="1.5" spread="11.17"/>
                    <measurement group_id="O3" value="4.4" spread="8.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours post last dose (n=48,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="9.70"/>
                    <measurement group_id="O2" value="0.3" spread="10.22"/>
                    <measurement group_id="O3" value="2.4" spread="8.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="10.31"/>
                    <measurement group_id="O2" value="1.8" spread="10.18"/>
                    <measurement group_id="O3" value="1.3" spread="9.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.5 hours post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="10.12"/>
                    <measurement group_id="O2" value="-0.0" spread="8.80"/>
                    <measurement group_id="O3" value="0.7" spread="7.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="10.58"/>
                    <measurement group_id="O2" value="0.6" spread="8.83"/>
                    <measurement group_id="O3" value="1.3" spread="7.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="8.87"/>
                    <measurement group_id="O2" value="1.7" spread="10.18"/>
                    <measurement group_id="O3" value="0.9" spread="7.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="11.08"/>
                    <measurement group_id="O2" value="0.6" spread="10.17"/>
                    <measurement group_id="O3" value="-0.0" spread="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="10.37"/>
                    <measurement group_id="O2" value="1.7" spread="9.61"/>
                    <measurement group_id="O3" value="0.9" spread="8.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="10.79"/>
                    <measurement group_id="O2" value="2.5" spread="8.90"/>
                    <measurement group_id="O3" value="1.6" spread="9.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Diastolic Blood Pressure</title>
        <description>Diastolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
        <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Diastolic Blood Pressure</title>
          <description>Diastolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).</description>
          <population>Intent to treat population</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Predose (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.5" spread="8.19"/>
                    <measurement group_id="O2" value="63.2" spread="6.82"/>
                    <measurement group_id="O3" value="63.6" spread="9.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.4" spread="9.32"/>
                    <measurement group_id="O2" value="62.0" spread="7.29"/>
                    <measurement group_id="O3" value="62.5" spread="8.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.8" spread="8.34"/>
                    <measurement group_id="O2" value="62.5" spread="7.61"/>
                    <measurement group_id="O3" value="61.6" spread="7.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 1 (n=51,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.4" spread="7.72"/>
                    <measurement group_id="O2" value="62.5" spread="7.47"/>
                    <measurement group_id="O3" value="62.3" spread="9.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 2 (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.7" spread="8.76"/>
                    <measurement group_id="O2" value="63.3" spread="6.75"/>
                    <measurement group_id="O3" value="60.8" spread="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 2 (n=47,50,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.1" spread="7.35"/>
                    <measurement group_id="O2" value="62.2" spread="7.61"/>
                    <measurement group_id="O3" value="61.7" spread="8.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 2 (n=46,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.8" spread="8.07"/>
                    <measurement group_id="O2" value="62.0" spread="8.15"/>
                    <measurement group_id="O3" value="62.3" spread="7.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.4" spread="7.27"/>
                    <measurement group_id="O2" value="62.0" spread="8.83"/>
                    <measurement group_id="O3" value="61.6" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.5" spread="8.88"/>
                    <measurement group_id="O2" value="62.1" spread="8.60"/>
                    <measurement group_id="O3" value="62.5" spread="8.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours post last dose (n=48,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.1" spread="9.09"/>
                    <measurement group_id="O2" value="62.3" spread="7.90"/>
                    <measurement group_id="O3" value="62.5" spread="9.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.8" spread="10.79"/>
                    <measurement group_id="O2" value="62.3" spread="6.87"/>
                    <measurement group_id="O3" value="62.1" spread="9.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.5 hours post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.7" spread="10.41"/>
                    <measurement group_id="O2" value="59.7" spread="7.97"/>
                    <measurement group_id="O3" value="62.3" spread="8.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.2" spread="8.85"/>
                    <measurement group_id="O2" value="61.4" spread="7.51"/>
                    <measurement group_id="O3" value="62.5" spread="9.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.0" spread="9.80"/>
                    <measurement group_id="O2" value="60.5" spread="6.54"/>
                    <measurement group_id="O3" value="62.6" spread="7.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.9" spread="10.15"/>
                    <measurement group_id="O2" value="63.1" spread="7.32"/>
                    <measurement group_id="O3" value="59.9" spread="8.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.6" spread="9.12"/>
                    <measurement group_id="O2" value="62.2" spread="7.84"/>
                    <measurement group_id="O3" value="61.9" spread="8.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.3" spread="8.75"/>
                    <measurement group_id="O2" value="63.0" spread="7.40"/>
                    <measurement group_id="O3" value="60.0" spread="8.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Predose in Mean Diastolic Blood Pressure</title>
        <description>Mean diastolic blood pressure measured at various timepoints minus the predose diastolic blood pressure</description>
        <time_frame>predose, various timeframes up to 5 hours post last dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose in Mean Diastolic Blood Pressure</title>
          <description>Mean diastolic blood pressure measured at various timepoints minus the predose diastolic blood pressure</description>
          <population>Intent to treat population</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="8.60"/>
                    <measurement group_id="O2" value="-1.1" spread="7.26"/>
                    <measurement group_id="O3" value="-1.0" spread="10.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 1 (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.7" spread="7.69"/>
                    <measurement group_id="O2" value="-0.6" spread="7.84"/>
                    <measurement group_id="O3" value="-1.9" spread="7.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 1 (n=51,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="7.89"/>
                    <measurement group_id="O2" value="-0.7" spread="7.71"/>
                    <measurement group_id="O3" value="-1.3" spread="9.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 min post dose 2 (n=50,51,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="8.10"/>
                    <measurement group_id="O2" value="0.1" spread="6.85"/>
                    <measurement group_id="O3" value="-2.8" spread="9.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post dose 2 (n=47,50,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="7.82"/>
                    <measurement group_id="O2" value="-1.1" spread="7.59"/>
                    <measurement group_id="O3" value="-1.9" spread="9.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post dose 2 (n=46,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="7.08"/>
                    <measurement group_id="O2" value="-1.3" spread="6.98"/>
                    <measurement group_id="O3" value="-1.8" spread="6.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="7.12"/>
                    <measurement group_id="O2" value="-1.2" spread="7.34"/>
                    <measurement group_id="O3" value="-1.9" spread="9.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="8.84"/>
                    <measurement group_id="O2" value="-1.1" spread="8.48"/>
                    <measurement group_id="O3" value="-1.1" spread="8.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours post last dose (n=48,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="8.00"/>
                    <measurement group_id="O2" value="-0.9" spread="7.23"/>
                    <measurement group_id="O3" value="-1.1" spread="9.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="10.16"/>
                    <measurement group_id="O2" value="-0.9" spread="7.70"/>
                    <measurement group_id="O3" value="-1.5" spread="9.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.5 hours post last dose (n=49,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="8.66"/>
                    <measurement group_id="O2" value="-3.5" spread="7.36"/>
                    <measurement group_id="O3" value="-1.3" spread="9.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="8.45"/>
                    <measurement group_id="O2" value="-1.8" spread="8.31"/>
                    <measurement group_id="O3" value="-1.1" spread="10.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="8.36"/>
                    <measurement group_id="O2" value="-2.6" spread="6.66"/>
                    <measurement group_id="O3" value="-1.0" spread="8.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="10.38"/>
                    <measurement group_id="O2" value="-0.0" spread="7.63"/>
                    <measurement group_id="O3" value="-3.7" spread="10.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4.5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="8.86"/>
                    <measurement group_id="O2" value="-1.0" spread="7.64"/>
                    <measurement group_id="O3" value="-1.7" spread="10.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours post last dose (n=50,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="8.84"/>
                    <measurement group_id="O2" value="-0.1" spread="8.06"/>
                    <measurement group_id="O3" value="-3.6" spread="10.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Serum Potassium Levels</title>
        <time_frame>Predose, 2 hours and 6 hours postdose 1</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Serum Potassium Levels</title>
          <population>Intent to treat population</population>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Predose (n=51,52,39)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.25" spread="0.376"/>
                    <measurement group_id="O2" value="4.27" spread="0.386"/>
                    <measurement group_id="O3" value="4.31" spread="0.325"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=48,47,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" spread="0.423"/>
                    <measurement group_id="O2" value="3.83" spread="0.391"/>
                    <measurement group_id="O3" value="3.71" spread="0.410"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=48,49,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.99" spread="0.334"/>
                    <measurement group_id="O2" value="3.95" spread="0.325"/>
                    <measurement group_id="O3" value="3.87" spread="0.435"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Predose in Mean Serum Potassium</title>
        <description>Change in mean serum potassium at the specified timepoint minus the predose value.</description>
        <time_frame>predose, 2 and 6 hours post dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose in Mean Serum Potassium</title>
          <description>Change in mean serum potassium at the specified timepoint minus the predose value.</description>
          <population>Intent to treat population</population>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 hours post dose 1 (n=48,47,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.58" spread="0.457"/>
                    <measurement group_id="O2" value="-0.42" spread="0.407"/>
                    <measurement group_id="O3" value="-0.62" spread="0.401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=48,49,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="0.307"/>
                    <measurement group_id="O2" value="-0.31" spread="0.450"/>
                    <measurement group_id="O3" value="-0.39" spread="0.424"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Serum Glucose Values</title>
        <time_frame>Predose, 2 and 6 hours post dose 1</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Serum Glucose Values</title>
          <population>Intent to treat population</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Predose (n=51,52,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.4" spread="15.59"/>
                    <measurement group_id="O2" value="87.5" spread="15.43"/>
                    <measurement group_id="O3" value="87.6" spread="17.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=48,47,39)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114.5" spread="30.42"/>
                    <measurement group_id="O2" value="108.6" spread="27.51"/>
                    <measurement group_id="O3" value="120.6" spread="32.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=49,48,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.6" spread="18.43"/>
                    <measurement group_id="O2" value="99.0" spread="15.78"/>
                    <measurement group_id="O3" value="106.3" spread="15.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Predose in Mean Serum Glucose</title>
        <description>Change in mean serum glucose at the specified timepoint minus the predose value.</description>
        <time_frame>predose, 2 and 6 hours post dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose in Mean Serum Glucose</title>
          <description>Change in mean serum glucose at the specified timepoint minus the predose value.</description>
          <population>Intent to treat population</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 hours post dose 1 (n=48,47,39)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.1" spread="34.74"/>
                    <measurement group_id="O2" value="22.4" spread="32.66"/>
                    <measurement group_id="O3" value="32.9" spread="35.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=49,48,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.3" spread="22.49"/>
                    <measurement group_id="O2" value="12.1" spread="20.59"/>
                    <measurement group_id="O3" value="18.6" spread="23.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Predose of Mean Forced Expiratory Volume in One Second (FEV1)</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. Change in FEV1 was calculated as postdose value minus the predose value at each visit.</description>
        <time_frame>predose, various postdose timepoints</time_frame>
        <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose of Mean Forced Expiratory Volume in One Second (FEV1)</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. Change in FEV1 was calculated as postdose value minus the predose value at each visit.</description>
          <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 minutes post dose 1 (n=37,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.160" spread="0.102"/>
                    <measurement group_id="O2" value="0.117" spread="0.112"/>
                    <measurement group_id="O3" value="0.133" spread="0.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 1 (n=37,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.159" spread="0.139"/>
                    <measurement group_id="O2" value="0.142" spread="0.151"/>
                    <measurement group_id="O3" value="0.158" spread="0.125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.199" spread="0.130"/>
                    <measurement group_id="O2" value="0.169" spread="0.154"/>
                    <measurement group_id="O3" value="0.175" spread="0.106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.194" spread="0.153"/>
                    <measurement group_id="O2" value="0.162" spread="0.166"/>
                    <measurement group_id="O3" value="0.183" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 3 (n=34,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.226" spread="0.144"/>
                    <measurement group_id="O2" value="0.179" spread="0.160"/>
                    <measurement group_id="O3" value="0.203" spread="0.148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 3 (n=35,38,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.226" spread="0.154"/>
                    <measurement group_id="O2" value="0.188" spread="0.150"/>
                    <measurement group_id="O3" value="0.205" spread="0.152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=36,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.216" spread="0.139"/>
                    <measurement group_id="O2" value="0.194" spread="0.146"/>
                    <measurement group_id="O3" value="0.218" spread="0.149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.163" spread="0.150"/>
                    <measurement group_id="O2" value="0.170" spread="0.175"/>
                    <measurement group_id="O3" value="0.198" spread="0.150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.098" spread="0.128"/>
                    <measurement group_id="O2" value="0.173" spread="0.165"/>
                    <measurement group_id="O3" value="0.174" spread="0.166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Peak Expiratory Flow Rate (PEFR)</title>
        <description>PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters.</description>
        <time_frame>predose, various postdose times</time_frame>
        <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Peak Expiratory Flow Rate (PEFR)</title>
          <description>PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters.</description>
          <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.</population>
          <units>liters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>predose (n=37,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.604" spread="0.949"/>
                    <measurement group_id="O2" value="3.546" spread="0.928"/>
                    <measurement group_id="O3" value="3.565" spread="0.675"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 1 (n=37,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.926" spread="0.900"/>
                    <measurement group_id="O2" value="3.788" spread="0.950"/>
                    <measurement group_id="O3" value="3.824" spread="0.613"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 1 (n=37,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.003" spread="0.893"/>
                    <measurement group_id="O2" value="3.877" spread="0.950"/>
                    <measurement group_id="O3" value="3.844" spread="0.698"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.053" spread="1.007"/>
                    <measurement group_id="O2" value="3.890" spread="0.998"/>
                    <measurement group_id="O3" value="3.925" spread="0.679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.047" spread="0.982"/>
                    <measurement group_id="O2" value="3.964" spread="0.912"/>
                    <measurement group_id="O3" value="3.989" spread="0.652"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 3 (n=34,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.156" spread="0.960"/>
                    <measurement group_id="O2" value="4.003" spread="0.993"/>
                    <measurement group_id="O3" value="4.077" spread="0.711"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 3 (n=35,38,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.176" spread="0.966"/>
                    <measurement group_id="O2" value="4.007" spread="0.899"/>
                    <measurement group_id="O3" value="4.017" spread="0.693"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=36,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.221" spread="0.961"/>
                    <measurement group_id="O2" value="4.178" spread="1.013"/>
                    <measurement group_id="O3" value="4.066" spread="0.668"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.155" spread="0.984"/>
                    <measurement group_id="O2" value="4.029" spread="1.061"/>
                    <measurement group_id="O3" value="4.039" spread="0.663"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.970" spread="0.938"/>
                    <measurement group_id="O2" value="4.058" spread="1.075"/>
                    <measurement group_id="O3" value="4.016" spread="0.628"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Predose in Mean Peak Expiratory Flow Rate (PEFR)</title>
        <description>PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters. Change in PEFR was calculated as postdose value minus the predose value at each visit.</description>
        <time_frame>predose, various postdose times</time_frame>
        <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Predose in Mean Peak Expiratory Flow Rate (PEFR)</title>
          <description>PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters. Change in PEFR was calculated as postdose value minus the predose value at each visit.</description>
          <population>Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.</population>
          <units>liters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 minutes post dose 1 (n=37,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.322" spread="0.305"/>
                    <measurement group_id="O2" value="0.242" spread="0.298"/>
                    <measurement group_id="O3" value="0.259" spread="0.396"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 1 (n=37,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.399" spread="0.367"/>
                    <measurement group_id="O2" value="0.320" spread="0.392"/>
                    <measurement group_id="O3" value="0.279" spread="0.442"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.458" spread="0.363"/>
                    <measurement group_id="O2" value="0.344" spread="0.369"/>
                    <measurement group_id="O3" value="0.360" spread="0.406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 2 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.452" spread="0.329"/>
                    <measurement group_id="O2" value="0.419" spread="0.363"/>
                    <measurement group_id="O3" value="0.424" spread="0.383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes post dose 3 (n=34,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.524" spread="0.343"/>
                    <measurement group_id="O2" value="0.457" spread="0.439"/>
                    <measurement group_id="O3" value="0.513" spread="0.466"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 3 (n=35,38,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.539" spread="0.375"/>
                    <measurement group_id="O2" value="0.462" spread="0.429"/>
                    <measurement group_id="O3" value="0.449" spread="0.497"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=36,37,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.575" spread="0.385"/>
                    <measurement group_id="O2" value="0.596" spread="0.596"/>
                    <measurement group_id="O3" value="0.501" spread="0.408"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.509" spread="0.345"/>
                    <measurement group_id="O2" value="0.484" spread="0.440"/>
                    <measurement group_id="O3" value="0.474" spread="0.449"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=36,38,27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.324" spread="0.337"/>
                    <measurement group_id="O2" value="0.513" spread="0.720"/>
                    <measurement group_id="O3" value="0.451" spread="0.462"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plasma Concentration of (R,R) Formoterol</title>
        <description>If the mean plasma concentration was 'below the limit of quantification' (BLQ) which was set as &lt;=0.5 picograms/milliliter, the value is displayed as a zero.</description>
        <time_frame>predose, various postdose times</time_frame>
        <population>PK population consisted of subjects who were in the intent-to-treat population and had any plasma concentration data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Levalbuterol 0.63 mg</title>
            <description>Values represent participant experience when treated with levalbuterol during the cross-over portion of the study</description>
          </group>
          <group group_id="O2">
            <title>Arformoterol 7.5 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study</description>
          </group>
          <group group_id="O3">
            <title>Arformoterol 15 Mcg</title>
            <description>Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Concentration of (R,R) Formoterol</title>
          <description>If the mean plasma concentration was 'below the limit of quantification' (BLQ) which was set as &lt;=0.5 picograms/milliliter, the value is displayed as a zero.</description>
          <population>PK population consisted of subjects who were in the intent-to-treat population and had any plasma concentration data available.</population>
          <units>picogram/milliliter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>predose (n=51,52,39)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.646" spread="3.4172"/>
                    <measurement group_id="O2" value="0" spread="0.5159"/>
                    <measurement group_id="O3" value="0.737" spread="2.7612"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 1 (n=50,46,36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.402" spread="15.1253"/>
                    <measurement group_id="O2" value="2.236" spread="13.0128"/>
                    <measurement group_id="O3" value="1.659" spread="2.4584"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes post dose 2 (n=48,47,36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0.8858"/>
                    <measurement group_id="O2" value="1.845" spread="2.8085"/>
                    <measurement group_id="O3" value="3.325" spread="2.3515"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post dose 1 (n=50,51,38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0.0000"/>
                    <measurement group_id="O2" value="1.885" spread="1.7035"/>
                    <measurement group_id="O3" value="4.189" spread="2.8207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post dose 1 (n=50,50,37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0.8899"/>
                    <measurement group_id="O2" value="0.874" spread="1.1988"/>
                    <measurement group_id="O3" value="2.818" spread="1.7195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Levalbuterol 0.63 mg</title>
          <description>The experience of participants when treated with levalbuterol during the cross-over portion of the study.</description>
        </group>
        <group group_id="E2">
          <title>Arformoterol 7.5 Mcg</title>
          <description>The experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study.</description>
        </group>
        <group group_id="E3">
          <title>Arformoterol 15 Mcg</title>
          <description>The experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MedDRA (11.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="52"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Stomach Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Viral Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Blood Potassium Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT Prolonged</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nasal Congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>In addition to the &lt;60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size was determined outside of statistical considerations. All data recorded at/after Visit 8 for 6 subjects, misdosed with ARF 7.5mcg instead of ARF 15mcg in open-label period, were excluded from the planned efficacy, PK and safety analyses.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Respiratory Medical Director</name_or_title>
      <organization>Sepracor Inc</organization>
      <phone>866-503-6351</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

